Oregon Medical Malpractice Lawyer
Personal Injury Attorney Serving Portland and Surrounding Areas
Under Oregon law, a physician has the duty to use that degree of care, skill, and diligence which is used by ordinarily careful physicians practicing in the same or similar circumstances in the same or a similar community. Physicians who are specialists in a particular field of medicine have the duty to use that degree of care, skill, and diligence which is used by ordinarily careful specialists practicing in the same medical field and in the same or a similar community. A failure to use such care, skill, or diligence is negligence.
All states have similar standards, but medical malpractice continues to cause serious personal injury or wrongful death to tens of thousands of patients each year. A doctor, surgeon, anesthesiologist, radiologist, oncologist, or other healthcare provider is not, of course, negligent merely because his or her efforts were unsuccessful. A physician does not guarantee a good result by undertaking to perform a service. When mistakes occur, however, patients can suffer catastrophic, permanent injury or even death. As a personal injury law firm that considers medical malpractice cases, we believe strongly in protecting patients when they suffer serious losses because of the medical system’s mistakes:
Misdiagnosis or Failure to Diagnose
Anesthesiological Mistakes
Improper Prescription or Administration of Medications
Improper Use of Medical Devices
Defective Medical Devices
Failure to Obtain Informed Consent
Failure to Order Diagnostic Tests or Consult Specialists
Failure to Monitor
Post-Operative Infection
Incorrect Treatment
Any type of medical negligence may cause serious injury or death. Complications of improper treatment or failure to diagnose may include:
Appendicitis and Gastrointestinal Perforations
Birth Injury
Blood Clots (Pulmonary Emboli)
Cancer
Heart Attack/Disease
Infection
Surgical Error
Medical Malpractice Case Evaluation
If you or a loved one have suffered because of any form of medical malpractice or neglect, including misdiagnosis or failure to diagnose cancer; serious injury or wrongful death due to anesthesia, drugs, or medical devices; surgical procedures performed without consent; serious injury or wrongful death due to failure to order tests, consult specialists, or monitor patients; or incorrect treatment of any other kind, contact us for a free initial consultation. We consider medical negligence cases carefully and may be unable to represent you, but we believe that every potential case of patient harm should be evaluated before any decision is made.
MedWatch Safety Alert RSS Feed
FDA MedWatch Safety Alerts
Zithromax (azithromycin): FDA Statement on risk of cardiovascular death May 17, 2012
Source: MedWatch Safety Alert RSS Feed |
Gilenya (fingolimod): Drug Safety Communication – Safety Review of a Reported Death After the First Dose May 14, 2012
Source: MedWatch Safety Alert RSS Feed |
Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall – May Contain More Than the Intended Fill Volume May 14, 2012
Source: MedWatch Safety Alert RSS Feed |
Revlimid (lenalidomide): Ongoing Safety Review – Increased Risk of Developing New Malignancies May 7, 2012
Source: MedWatch Safety Alert RSS Feed |
Certain Compounded Drugs from Franck’s: FDA Issues Second Warning to Physicians May 4, 2012
Source: MedWatch Safety Alert RSS Feed |
Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication – Drug Interactions April 26, 2012
Source: MedWatch Safety Alert RSS Feed |
X-Rock: Recall – Undeclared Drug Ingredient April 25, 2012
Source: MedWatch Safety Alert RSS Feed |
Roche Diagnostics Operations Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays: Recall – Doctors may receive a falsely low result April 24, 2012
Source: MedWatch Safety Alert RSS Feed |
Brilliant Blue G Compounded by Franck’s: Recall of Unapproved Drug – Ongoing Investigation of Fungal Endophthalmitis Cases April 20, 2012
Source: MedWatch Safety Alert RSS Feed |
Aliskiren-containing Medications: Drug Safety Comunication – New Warning and Contraindication April 20, 2012
Source: MedWatch Safety Alert RSS Feed |
Other‐Sonic Generic Ultrasound Transmission Gel: Safety Communication – Risk of Bacterial Contamination April 18, 2012
Source: MedWatch Safety Alert RSS Feed |
Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall – May Contain More Than Intended Fill Volume April 18, 2012
Source: MedWatch Safety Alert RSS Feed |
Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots April 10, 2012
Source: MedWatch Safety Alert RSS Feed |
Thoratec Corporation, HeartMate II Left Ventricular Assist System (LVAS): Class 1 Recall- Outflow Graft May Kink or Deform April 4, 2012
Source: MedWatch Safety Alert RSS Feed |
Altuzan (bevacizumab): Counterfeit Product – Contains no Active Ingredient April 3, 2012
Source: MedWatch Safety Alert RSS Feed |
Celexa (citalopram hydrobromide) – Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms March 28, 2012
Source: MedWatch Safety Alert RSS Feed |
Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall – Potential for Visible Particulates March 23, 2012
Source: MedWatch Safety Alert RSS Feed |
Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury March 15, 2012
Source: MedWatch Safety Alert RSS Feed |
Acclarent Inspira AIR Balloon Dilation System: Class 1 Recall – Potential For Balloon To Not Deflate Or To Deflate To Slowly March 13, 2012
Source: MedWatch Safety Alert RSS Feed |
Gerber Good Start Gentle Powdered Infant Formula: Recall – Off-Odor March 9, 2012
Source: MedWatch Safety Alert RSS Feed |
Portland injury lawyer Dane E. Johnson is committed to helping to reduce medical malpractice, improve medical device safety, and keep consumers aware of dangerous drugs and medical products. We are pleased to make the above MedWatch Safety Alerts available as soon as they are published by the United States Food and Drug Administration (FDA). Contact us for more information on any of these alerts.
